Melanoma brain metastases affect up to 40% of stage IV patients. Discover 2026 SRS treatment options, immunotherapy combinations, survival rates & expert-backed next steps.
Stage 4 melanoma survival has reached 35–52% with 2026 immunotherapy and TIL therapy breakthroughs. This complete patient guide covers prognosis, treatment options, and your first steps after diagnosis.
Mohs surgery is now NCCN-approved for melanoma in situ and lentigo maligna. Discover who qualifies, real recurrence data, and 2026 cost breakdown.
Discover 500+ open melanoma clinical trials in 2026, including mRNA vaccine and CAR-T studies. Step-by-step guide to finding trials and qualifying fast.
Radiation therapy for melanoma uses high-energy beams to destroy cancer cells. Covers 6 types, indications, side effects, and the 2026 immunotherapy combination breakthrough.
BRAF-targeted therapy uses oral precision drugs to block melanoma's mutated BRAF protein. Discover FDA-approved drugs, who qualifies, and how to manage side effects. Updated April 2026.
Learn how immunotherapy works against melanoma, which 5 FDA-approved drugs exist, who qualifies by stage, and what 2026 survival rates actually mean for you.
Wide local excision for melanoma removes the tumor plus a 0.5–2 cm margin. 2026 surgeon-reviewed guide covers procedure steps, recovery timeline, and scar care.
Diagnosed with melanoma in 2026? This complete guide covers every FDA-approved treatment option—surgery, immunotherapy, BRAF therapy, TIL therapy, and the breakthrough mRNA vaccine trial.
Melanoma survival rate ranges from 99% at Stage 0 to 35–52% at Stage 4 with immunotherapy. See the complete 2026 data table, stage-by-stage breakdown, and what it means for you.
Confused by your melanoma blood test results? LDH, ctDNA, S100B, and BRAF biomarkers fully explained with a stage-by-stage guide and 2026 treatment insights.